SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-002740
Filing Date
2018-09-14
Accepted
2018-09-14 07:50:43
Documents
37
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannapharmarx_10q-063017.htm 10-Q 193787
2 CERTIFICATION PURSUANT TO cannapharmarx_10q-ex3101.htm EX-31.1 8462
3 CERTIFICATION cannapharmarx_10q-ex3102.htm EX-31.2 7981
4 CERTIFICATION cannapharmarx_10q-ex32.htm EX-32 4322
  Complete submission text file 0001683168-18-002740.txt   1028308

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20170630.xml EX-101.INS 112027
6 XBRL SCHEMA FILE cpmd-20170630.xsd EX-101.SCH 12904
7 XBRL CALCULATION FILE cpmd-20170630_cal.xml EX-101.CAL 25029
8 XBRL DEFINITION FILE cpmd-20170630_def.xml EX-101.DEF 17948
9 XBRL LABEL FILE cpmd-20170630_lab.xml EX-101.LAB 93358
10 XBRL PRESENTATION FILE cpmd-20170630_pre.xml EX-101.PRE 73604
Mailing Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614
Business Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 181070085
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1